Essex Investment Management’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Essex Investment Management’s Portfolio OREX Stock Details OREX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-43,366	Closed	-$2.82M	–	406
2014 Q1	$2.82M	Sell	43,366 -11,112	-20%	-$752K	0.41%	65
2013 Q4	$3.07M	Sell	54,478 -4,067	-7%	-$229K	0.43%	61
2013 Q3	$3.59M	Sell	58,545 -2,811	-5%	-$190K	0.54%	50
2013 Q2	$3.59M	Buy	+61,356	New	+$3.77M	0.63%	43

Other funds holding OREX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Essex Investment Management's OREX Position: Q2 2014 in Review

Essex Investment Management sold out of Orexigen Therapeutics, Inc. (OREX) in Q2 2014, closing a stake of 43,366 shares — an estimated $2.82M sold.

Essex Investment Management first reported a position in OREX in Q2 2013 and held it in 4 quarters. The position peaked at $3.59M in Q3 2013. 129 funds tracked by Wall St. Rank hold OREX as of Q2 2014.

Essex Investment Management reported no remaining Orexigen Therapeutics, Inc. position as of Q2 2014 after selling out during the quarter.
Essex Investment Management sold 43,366 Orexigen Therapeutics, Inc. shares in Q2 2014, an estimated $2.82M.
Essex Investment Management first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 4 quarters.
Essex Investment Management's Orexigen Therapeutics, Inc. position peaked at $3.59M in Q3 2013.
129 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q2 2014.

Based on Essex Investment Management's 13F filing for Q2 2014, filed 23 Jul 2014.